Eton Pharmaceuticals, Inc. (ETON)
USD 11.91
(-5.78%)
USD 11.91
(-5.78%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 31.64 Million | 21.25 Million | 21.83 Million | 39 Thousand | 959 Thousand | - |
| Cost of Revenue | 10.58 Million | 6.93 Million | 2.62 Million | 286 Thousand | 453 Thousand | 63 Thousand |
| Gross Profit | 21.06 Million | 14.31 Million | 19.2 Million | -247 Thousand | 506 Thousand | -63 Thousand |
| Operating Expenses | 22.25 Million | 22.57 Million | 20.7 Million | 26.86 Million | 19.1 Million | 10.32 Million |
| Selling, General and Administrative Expenses | 18.93 Million | 18.58 Million | 14.46 Million | 12.76 Million | 7.55 Million | 4.69 Million |
| Research and Development Expenses | 3.32 Million | 3.99 Million | 6.23 Million | 14.1 Million | 11.55 Million | 5.62 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 32.83 Million | 29.51 Million | 23.32 Million | 27.15 Million | 19.56 Million | 10.32 Million |
| Operating Income | -1.19 Million | -8.26 Million | -1.49 Million | -27.11 Million | -18.6 Million | -10.32 Million |
| Interest Expense | - | 955 Thousand | 1 Million | 889 Thousand | - | - |
| Income Tax Expense | 247 Thousand | 761 Thousand | 1 Million | 859 Thousand | -281 Thousand | -2.58 Million |
| Earnings before Tax | -689 Thousand | -9.02 Million | -1.95 Million | -27.97 Million | -18.32 Million | -12.74 Million |
| Net Income | -936 Thousand | -9.78 Million | -2.96 Million | -28.82 Million | -18.03 Million | -12.74 Million |
| Earnings Per Share Basic | -0.04 | -0.39 | -0.12 | -1.37 | -1.02 | -1.99 |
| Earnings Per Share Diluted | -0.04 | -0.39 | -0.12 | -1.37 | -1.02 | -1.99 |
| Weighted Average Shares Outstanding | 25.64 Million | 25.14 Million | 25.2 Million | 21.01 Million | 17.76 Million | 6.41 Million |
| Weighted Average Shares Outstanding (Diluted) | 25.64 Million | 25.14 Million | 25.2 Million | 21.01 Million | 17.76 Million | 6.41 Million |
| Gross Margin | 0.67 | 0.67 | 0.88 | -6.33 | 0.53 | - |
| EBIT Margin | -0.01 | -0.31 | -0.05 | -678.46 | -18.93 | - |
| Profit Margin | -0.03 | -0.46 | -0.14 | -739.21 | -18.81 | - |
| EBITDA | -291 Thousand | -6.48 Million | -1.12 Million | -26.46 Million | -18.15 Million | -10.25 Million |
| Earnings Before Tax Margin | -0.04 | -0.39 | -0.07 | -695.15 | -19.40 | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 9.07 Million | 7.96 Million | 7.31 Million | 31.64 Million | 7.02 Million | 11.99 Million |
| Cost of Revenue | 3.44 Million | 2.95 Million | 3.68 Million | 10.58 Million | 2.62 Million | 2.31 Million |
| Gross Profit | 5.62 Million | 5 Million | 3.63 Million | 21.06 Million | 4.4 Million | 9.68 Million |
| Operating Expenses | 8.56 Million | 5.8 Million | 5.62 Million | 22.25 Million | 4.95 Million | 5.79 Million |
| Selling, General and Administrative Expenses | 5.59 Million | 5.15 Million | 4.57 Million | - | 4.33 Million | 4.67 Million |
| Research and Development Expenses | 2.97 Million | 651 Thousand | 1.04 Million | - | 615 Thousand | 1.12 Million |
| Other Expenses | - | - | -800 Thousand | - | - | 800 Thousand |
| Cost and Expenses | 12 Million | 8.76 Million | 9.3 Million | 32.83 Million | 7.57 Million | 8.11 Million |
| Operating Income | -2.93 Million | -800 Thousand | -1.99 Million | -1.19 Million | -548 Thousand | 3.88 Million |
| Interest Expense | 52 Thousand | 11 Thousand | 222 Thousand | 503 Thousand | 31 Thousand | 124 Thousand |
| Income Tax Expense | 54 Thousand | 208.72 Thousand | 247 Thousand | 247 Thousand | 241.58 Thousand | 713 Thousand |
| Earnings before Tax | -2.98 Million | -811 Thousand | -2 Million | -689 Thousand | -579 Thousand | 4.55 Million |
| Net Income | -3.04 Million | -811 Thousand | -2.25 Million | -936 Thousand | -579 Thousand | 4.55 Million |
| Earnings Per Share Basic | -0.12 | -0.03 | -0.09 | - | -0.02 | 0.18 |
| Earnings Per Share Diluted | -0.12 | -0.03 | -0.09 | - | -0.02 | 0.18 |
| Weighted Average Shares Outstanding | 25.77 Million | 25.76 Million | 25.74 Million | 25.64 Million | 25.71 Million | 25.59 Million |
| Weighted Average Shares Outstanding (Diluted) | 25.77 Million | 25.76 Million | 25.74 Million | 25.64 Million | 25.71 Million | 25.98 Million |
| Gross Margin | 0.62 | 0.63 | 0.50 | 0.67 | 0.63 | 0.81 |
| EBIT Margin | -0.29 | -0.07 | -0.23 | - | -0.05 | 0.39 |
| Profit Margin | -0.34 | -0.10 | -0.31 | -0.03 | -0.08 | 0.38 |
| EBITDA | -2.65 Million | -548 Thousand | -1.71 Million | - | -346 Thousand | 4.68 Million |
| Earnings Before Tax Margin | -0.32 | -0.10 | -0.27 | -0.04 | -0.08 | 0.32 |
DUST
PDES
SQZB
MGLUY
UGHB
2852